Page 2 - Hong Kong (HSI) Growth Pharmaceuticals & Biotech Stocks

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

UPDATED Jan 08, 2026

Discover Hong Kong Pharmaceuticals & Biotech Growth Stocks that are on the HSI. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.

123 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
1521 Frontage Holdings	HK$0.99	-2.0%	-35.7%	HK$2.0b	HK$1.20	PE67.2x	E37.0%	n/a
2186 Luye Pharma Group	HK$3.02	9.0%	47.3%	HK$11.8b	HK$3.59	PE27.2x	E30.7%	0%
6855 Ascentage Pharma Group International	HK$54.95	8.0%	38.4%	HK$20.0b	HK$91.03	PS46.4x	E27.2%	n/a
1801 Innovent Biologics	HK$89.30	13.3%	166.2%	HK$153.2b	HK$111.74	PE121.6x	E27.2%	n/a
2268 WuXi XDC Cayman	HK$70.90	15.6%	114.8%	HK$85.8b	HK$80.16	PE60.1x	E26.3%	n/a
2096 Simcere Pharmaceutical Group	HK$12.15	3.0%	85.2%	HK$31.5b	HK$16.15	PE32.1x	E24.2%	1.5%
6826 Shanghai Haohai Biological Technology	HK$25.68	5.7%	4.2%	HK$10.6b	HK$37.13	PE13.5x	E21.8%	4.3%
2561 VISEN Pharmaceuticals	HK$33.68	0.2%	n/a	HK$3.5b	HK$83.17	PS3767.6x	E18.7%	n/a
1666 Tong Ren Tang Technologies	HK$4.49	1.1%	-6.8%	HK$5.7b	HK$6.20	PE11.9x	E16.4%	4.4%
3320 China Resources Pharmaceutical Group	HK$4.61	2.2%	-12.9%	HK$29.0b	HK$6.78	PE9.3x	E16.0%	3.0%
2410 TYK Medicines	HK$14.30	10.6%	-30.2%	HK$5.2b	HK$23.99	PS45501.7x	E14.8%	n/a
2161 JBM (Healthcare)	HK$2.77	4.5%	61.0%	HK$2.3b	HK$3.53	PE10.5x	E14.5%	7.0%
867 China Medical System Holdings	HK$14.20	8.3%	98.9%	HK$33.8b	HK$16.95	PE18.6x	E14.3%	2.1%
3613 Beijing Tong Ren Tang Chinese Medicine	HK$8.61	2.4%	6.8%	HK$7.2b	HK$10.75	PE14x	E13.8%	4.1%
1061 Essex Bio-Technology	HK$4.16	9.2%	49.6%	HK$2.3b	HK$6.84	PE7.5x	E13.7%	3.4%
2005 SSY Group	HK$3.05	6.6%	-4.1%	HK$8.9b	HK$3.99	PE13.4x	E13.2%	4.8%
2269 WuXi Biologics (Cayman)	HK$37.06	13.9%	115.5%	HK$150.4b	HK$39.84	PE32.7x	E12.9%	n/a
2162 Keymed Biosciences	HK$58.55	9.5%	110.2%	HK$17.3b	HK$82.56	PS17.7x	E12.6%	n/a
1681 Consun Pharmaceutical Group	HK$16.07	3.3%	111.4%	HK$13.2b	HK$18.67	PE12x	E12.5%	4.1%
512 Grand Pharmaceutical Group	HK$7.90	1.3%	78.3%	HK$27.7b	HK$11.61	PE13.3x	E12.3%	3.3%
3692 Hansoh Pharmaceutical Group	HK$41.60	14.2%	156.2%	HK$246.6b	HK$45.31	PE47.2x	E12.3%	0.9%
1093 CSPC Pharmaceutical Group	HK$9.18	8.3%	110.1%	HK$103.9b	HK$10.14	PE23.1x	E11.6%	2.8%
2633 Jacobson Pharma	HK$1.29	0%	27.7%	HK$2.6b	HK$2.53	PE8.5x	E8.5%	7.6%
1177 Sino Biopharmaceutical	HK$6.83	7.4%	138.8%	HK$121.2b	HK$9.57	PE28.1x	E7.2%	1.5%

Page 2 of 6